Lycopene and gene expression in benign prostate: a phase II randomized trial

被引：1
|
作者：
Gann, Peter H. [1 ]
Dai, Yang [1 ]
Giangreco, Angeline Antonio [1 ]
Deaton, Ryan [1 ]
van Breemen, Richard [1 ]
Lu, Yi [1 ]
Rueter, Erika Enk [1 ]
Nonn, Larisa [1 ]
机构：
[1] Univ Illinois, Chicago, IL USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-LB-217
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-217
引用
收藏
页数：1
相关论文
共 50 条
  • [1] ANTIOXIDANT EFFECTS OF LYCOPENE IN MEN WITH PROSTATE CANCER OR BENIGN PROSTATE HYPERPLASIA: A RANDOMIZED CONTROLLED TRIAL
    van Breemen, Richard B.
    Sharifi, Roohollah
    Viana, Marlos
    Bowen, Phyllis E.
    Stacewicz-Sapuntzakis, Maria
    PHARMACEUTICAL BIOLOGY, 2012, 50 (05) : 631 - 631
  • [2] Antioxidant Effects of Lycopene in African American Men with Prostate Cancer or Benign Prostate Hyperplasia: A Randomized, Controlled Trial
    van Breemen, Richard B.
    Sharifi, Roohollah
    Viana, Marlos
    Pajkovic, Natasa
    Zhu, Dongwei
    Yuan, Long
    Yang, Yanan
    Bowen, Phyllis E.
    Stacewicz-Sapuntzakis, Maria
    CANCER PREVENTION RESEARCH, 2011, 4 (05) : 711 - 718
  • [3] Gene Expression and Biological Pathways in Tissue of Men with Prostate Cancer in a Randomized Clinical Trial of Lycopene and Fish Oil Supplementation
    Magbanua, Mark Jesus M.
    Roy, Ritu
    Sosa, Eduardo V.
    Weinberg, Vivian
    Federman, Scott
    Mattie, Michael D.
    Hughes-Fulford, Millie
    Simko, Jeff
    Shinohara, Katsuto
    Haqq, Christopher M.
    Carroll, Peter R.
    Chan, June M.
    PLOS ONE, 2011, 6 (09):
  • [4] Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy
    Kucuk, O
    Sarkar, FH
    Sakr, W
    Djuric, Z
    Pollak, MN
    Khachik, F
    Li, YW
    Banerjee, M
    Grignon, D
    Bertram, JS
    Crissman, JD
    Pontes, EJ
    Wood, DP
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2001, 10 (08) : 861 - 868
  • [5] ProDiet: A Phase II Randomized Placebo-controlled Trial of Green Tea Catechins and Lycopene in Men at Increased Risk of Prostate Cancer
    Lane, J. Athene
    Er, Vanessa
    Avery, Kerry N. L.
    Horwood, Jeremy
    Cantwell, Marie
    Caro, Gema P.
    Crozier, Alan
    Smith, George Davey
    Donovan, Jenny L.
    Down, Liz
    Hamdy, Freddie C.
    Gillatt, David
    Holly, Jeff
    Macefield, Rhiannon
    Moody, Hilary
    Neal, David E.
    Walsh, Eleanor
    Martin, Richard M.
    Metcalfe, Chris
    CANCER PREVENTION RESEARCH, 2018, 11 (11) : 687 - 696
  • [6] Quality assurance of a randomized phase II trial on urethrasparing prostate SBRT
    Jaccard, Maud
    Jaccard, M.
    Zilli, T.
    Dubouloz, A.
    Tsvang, L.
    Linthout, N.
    Verbakel, W.
    Bjorkqvist, M.
    Escude, L.
    Lencart, J.
    Ozen, Z.
    Perez-Moreno, J.
    Rouzaud, M.
    Miralbell, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (12) : 1125 - 1126
  • [7] A PHASE II RANDOMIZED CLINICAL TRIAL OF YOGA IN MEN WITH PROSTATE CANCER
    Kates, Max
    Mansour, Ahmed
    Lamm, Donald
    Shore, Neal
    Cavanna-Mast, Rose Marie
    Maulhardt, Holly
    diZerega, Gere
    JOURNAL OF UROLOGY, 2021, 206 : E1175 - E1175
  • [8] A randomized trial of lycopene supplementation in tobago men with high prostate cancer risk
    Bunker, Clareann H.
    McDonald, Alicia C.
    Evans, Rhobert W.
    de la Rosa, Noreen
    Boumosleh, Jocelyne Matar
    Patrick, Alan L.
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2007, 57 (02): : 130 - 137
  • [9] HDR Brachytherapy as Monotherapy for Prostate Cancer: Early Toxicity of a Randomized Phase II Trial
    Jolicoeur, M.
    Derashodian, T.
    Nguyen-Huynh, T.
    Hillmann, E. de Castro
    Berbiche, D.
    Truchon, D.
    Heliou, R.
    Mondat, M.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S90 - S91
  • [10] Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial
    Smith, David C.
    Smith, Matthew R.
    Sweeney, Christopher
    Elfiky, Aymen A.
    Logothetis, Christopher
    Corn, Paul G.
    Vogelzang, Nicholas J.
    Small, Eric J.
    Harzstark, Andrea L.
    Gordon, Michael S.
    Vaishampayan, Ulka N.
    Haas, Naomi B.
    Spira, Alexander I.
    Lara, Primo N., Jr.
    Lin, Chia-Chi
    Srinivas, Sandy
    Sella, Avishay
    Schoeffski, Patrick
    Scheffold, Christian
    Weitzman, Aaron L.
    Hussain, Maha
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04) : 412 - 419
12345